Blog

A new interesting article has been published in Zhonghua Bing Li Xue Za Zhi. 2020 Mar 26; 49(0):E011. doi: 10.3760/cma.j.cn112151-20200318-00221. [Epub ahead of print] and titled:

[Interpretation of pathological changes for “Guidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission (Trial Versio…

Authors of this article are:

Ding YQ, Bian XW.

A summary of the article is shown below:

in Chinese国家卫生健康委员会发布《新型冠状病毒肺炎诊疗方案（试行第七版）》，首次将病理变化纳入其中。这些病理变化信息是基于当时所获得的有限病例病理观察（重庆和武汉共7例遗体穿刺、5例系统尸检）结果，经过多名病理专家和临床专家讨论总结并达成共识，是目前较为全面的新型冠状病毒感染疾病（COVID-19）病理变化的总结，是COVID-19诊疗方案的重要指导性指标。本文根据COVID-19病理学研究结果，结合严重急性呼吸综合征（SARS）的病理变化，对两种疾病的多器官病理变化进行了比较分析，发现COVID-19与SARS导致的机体病理变化大致相同，主要病变发生在肺、免疫系统（脾脏、淋巴结）及各器官的血管，但SARS肺、脾脏及各器官的血管病变严重且广泛，而COVID-19 Ⅱ型肺泡上皮细胞的增生不如SARS显著，肺内支气管内甚至肺泡腔内可见较多支气管栓，SARS则少见，这可能是通气和换气功能障碍的直接而重要的病理基础，关于COVID-19病理变化，由于掌握的材料有限，尚需将来积累更多的尸体解剖资料予以补充，目前相关的病理变化信息仅供参考。.

Check out the article’s website on Pubmed for more information:

[link-preview url=https://www.ncbi.nlm.nih.gov/pubmed/32213267 forceshot=true]

This article is a good source of information and a good way to become familiar with topics such as: COVID-19; SARS-COV-2; 2019-nCoV; Coronavirus.

---

New Research Kits from MOLECULAR DEPOT

---

New Antibodies from MOLECULAR DEPOT

---

New Proteins from MOLECULAR DEPOT

---

New Chemicals from MOLECULAR DEPOT